Valuation GKB Ophthalmics Limited
Stocks
GKB
INE265D01015
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.49 INR | +4.34% |
|
+0.35% | +12.20% |
Company Valuation: GKB Ophthalmics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 216.7 | 413.3 | 463.7 | 547.2 | 439.6 | 304.1 |
| Change | - | 90.7% | 12.2% | 17.99% | -19.65% | -30.82% |
| Enterprise Value (EV) 1 | 236.6 | 363.7 | 423.1 | 518.2 | 382.4 | 319.7 |
| Change | - | 53.71% | 16.34% | 22.46% | -26.2% | -16.39% |
| P/E | -11.8x | -45.5x | 36.4x | -327x | -15.6x | -4.32x |
| PBR | 0.37x | 0.66x | 0.73x | 0.87x | 0.74x | 0.58x |
| PEG | - | 0.9x | -0x | 3x | -0x | -0x |
| Capitalization / Revenue | 0.37x | 0.73x | 0.65x | 0.72x | 0.5x | 0.28x |
| EV / Revenue | 0.4x | 0.64x | 0.6x | 0.69x | 0.43x | 0.29x |
| EV / EBITDA | 10x | 15.3x | 8.55x | 14.1x | 66.2x | -10.9x |
| EV / EBIT | -18.8x | -48.1x | 18.5x | 60.5x | -16.5x | -5.3x |
| EV / FCF | -6.6x | -38.7x | -25.6x | -8.45x | 15.9x | -6.64x |
| FCF Yield | -15.2% | -2.58% | -3.9% | -11.8% | 6.28% | -15.1% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -3.65 | -1.8 | 2.528 | -0.3321 | -5.58 | -13.98 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 585.3 | 568.8 | 709.4 | 754.7 | 882.5 | 1,090 |
| EBITDA 1 | 23.57 | 23.83 | 49.52 | 36.83 | 5.779 | -29.45 |
| EBIT 1 | -12.57 | -7.568 | 22.85 | 8.561 | -23.2 | -60.31 |
| Net income 1 | -18.4 | -9.075 | 12.74 | -1.674 | -28.1 | -70.45 |
| Net Debt 1 | 19.86 | -49.64 | -40.6 | -28.99 | -57.22 | 15.59 |
| Reference price 2 | 43.00 | 82.00 | 92.00 | 108.55 | 87.22 | 60.34 |
| Nbr of stocks (in thousands) | 5,041 | 5,041 | 5,041 | 5,041 | 5,041 | 5,041 |
| Announcement Date | 9/4/20 | 9/3/21 | 9/7/22 | 8/22/23 | 7/25/24 | 7/24/25 |
1INR in Million2INR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 3.01M | ||
| 28.87x | 2.79x | 11.78x | 2.5% | 85.56B | ||
| 31.21x | 3.22x | 12.19x | 0.51% | 33.28B | ||
| 34.52x | 3.7x | 11.87x | -.--% | 13.71B | ||
| 121.28x | 8.38x | 39.71x | -.--% | 10.04B | ||
| 18.12x | 4.41x | 12.52x | 1.54% | 1.81B | ||
| 14.77x | 3.8x | 8.66x | 1.81% | 1.4B | ||
| 24.1x | 4.87x | 14.95x | 2.16% | 801M | ||
| 12.94x | 2.63x | 6.77x | 3.12% | 787M | ||
| 18.71x | 1.27x | 7.57x | 1.71% | 759M | ||
| Average | 33.84x | 3.90x | 14.00x | 1.48% | 14.81B | |
| Weighted average by Cap. | 35.76x | 3.38x | 13.72x | 1.63% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- GKB Stock
- Valuation GKB Ophthalmics Limited
Select your edition
All financial news and data tailored to specific country editions
















